Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis

Pulmonary fibrosis (PF) is a chronic interstitial lung disease characterized by structural damage to the lung parenchyma, excessive deposition of extracellular matrix (ECM), and irreversible decline in lung function. Current pharmacological treatments cannot effectively reverse fibrosis, highlightin...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yingxu Wu, Hao Yan, Pin Li, Yongming Liu, Jiapeng Leng, Yuwei Cui, Xiaodong Lv, Lijian Pang, Ningzi Zang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-04-01
Serie:	Frontiers in Medicine
Soggetti:	gut microbiome gut microbiota gut-lung axis microbial metabolites pulmonary fibrosis
Accesso online:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1817835/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!